Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

VERS vs SANG: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

VERS Captures Overall Composite Edge (48.3 HOLD vs 48.5 HOLD), While SANG Leads 5–0 on Growth & Valuation Pillars

VERS Overall Winner 6-Pillar Tally: VERS 0 – 5 SANG (1 Tie) Matrix Metrics: VERS 0 – 8 SANG

As of Nov 16, 2026, VERS (VERS) captures the overall head-to-head institutional edge over Sangoma Technologies Corporation Common Shares (SANG) on higher Unified Composite conviction (48.3/100 HOLD vs. 48.5/100 HOLD) after splitting the core matrix 0–8 (led by composite factor balance), while SANG wins 5–0 across the 6-pillar growth and valuation breakdown. VERS trades at $71.45 (N/M Forward P/E, N/A operating margin) versus SANG at $4.71 (N/M Forward P/E, -6.8% operating margin).

  • Growth vs. Quality Trade-Off: VERS earns the overall head-to-head edge with a stronger Unified Composite Score (48.3/100 HOLD vs. SANG 48.5/100 HOLD) and 2.07β · 24% Vol risk profile, whereas SANG leads top-line expansion (-21.2% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About VERS vs SANG
VERS US Equity Head-to-Head Winner
VERS
Institutional Equity
$71.45
-1.6% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 2.07β · 24% Vol
Unified Composite Score
48.3 / 100 HOLD
Tech 47.0 Fund 47.0 Flow 50.0 Mom 56.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 43
RSI-14: 43.3 · SMA20: $73.49 · SMA50: $72.27
SANG NASDAQ
Sangoma Technologies Corporation Common Shares
Services-Computer Programming, Data Processing, Etc.
$4.71
-1.15% 1D
Market Cap $159.9M
TTM Revenue $200M
Forward P/E N/M
Beta / 30D Vol 0.04β · 21% Vol
Unified Composite Score
48.5 / 100 HOLD
Tech 46.0 Fund 48.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (6.4% over 20 days), RSI 57
RSI-14: 57.0 · SMA20: $4.66 · SMA50: $4.39

6-Pillar Scorecard Institutional Category Breakdown (VERS 0 – 5 SANG)

Columns: Metric · VERS · SANG
1. Valuation Multiples SANG
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M 0.8x
2. Growth & Scale SANG
Revenue Growth (YoY) N/A -21.2%
Earnings Growth (YoY) N/A +0.0%
TTM Revenue (USD) N/A $200M
Market Cap N/A $159.9M
3. Profitability & Quality SANG
Gross Margin N/A 70.3%
Operating Margin N/A -6.8%
Net Profit Margin N/A -40.5%
Return on Equity (ROE) N/A -37.8%
4. Balance Sheet & Cash Flow SANG
Cash Generation (TTM) N/A $4.9M EBITDA
Cash Flow Margin N/A 2.5% EBITDA Mgn
Net Cash / Leverage N/A ROE $5.24 Book/Sh · -37.8% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 57.2% (100th %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markup
6. R&D & Supply-Chain Moat SANG
OpEx & R&D Intensity N/A 77.1% of Rev ($154M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Software - Infrastructure Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: VERS (0) vs SANG (8)
Institutional Metric VERS SANG Criterion Row Edge
Market Capitalization
Scale
N/A $159.9M Larger Scale SANG
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A -21.2% Higher Growth SANG
Operating Margin (TTM)
Profitability
N/A -6.8% Higher Margin SANG
Net Profit Margin
Profitability
N/A -40.5% Higher Margin SANG
Return on Equity (ROE)
Capital Efficiency
N/A -37.8% Higher ROE SANG
52-Week Range Position
Momentum
61% ($51–$85) 65% ($3–$5) Stronger Trend SANG
Beta / 30D Volatility
Risk Regime
2.07β · 24% Vol 0.04β · 21% Vol Lower Realized Risk SANG
Unified Institutional Score
Composite Signal
48.3 / 100 (HOLD) 48.5 / 100 (HOLD) Higher Composite SANG
Trailing 12M Revenue (USD)
Operating Scale
N/A $200M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 70.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 0.8x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) $4.9M EBITDA ($5.24 Book/Sh · -37.8% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SANG +25.95 pp
VERS: +0.49% · SANG: +26.44%
3M Horizon SANG +24.04 pp
VERS: -2.99% · SANG: +21.05%
6M Horizon VERS +19.9 pp
VERS: +40.95% · SANG: +21.05%
1Y Horizon VERS +14.64 pp
VERS: +12.98% · SANG: -1.66%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VERS vs SANG. Trailing 12-month operating profitability (VERS N/A vs SANG -6.8%) and valuation multiples (VERS N/M vs SANG N/M Forward P/E) are benchmarked directly in Pillar 4 below.

VERS ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
SANG ADR TTM Benchmark FX-Normalized USD
TTM Revenue$200M
Gross Margin70.3%
Op. Margin-6.8%
ROE / Fwd P/E-37.8% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
VERS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 57.2%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact VERS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SANG UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SANG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
VERS Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
SANG Moat Profile Cyclical / Execution-Driven Positioning
Software - Infrastructure Operator
Competes within the Software - Infrastructure value chain with $159.9M market capitalization and -6.8% operating margin.
OpEx & R&D Reinvestment 77.1% of Rev ($154M)
90D Engineering Disclosures 0 Published

Investor FAQ VERS vs SANG Key Questions & Quantitative Answers

As of Nov 16, 2026, VERS (VERS) captures the overall head-to-head institutional edge over Sangoma Technologies Corporation Common Shares (SANG) on higher Unified Composite conviction (48.3/100 HOLD vs. 48.5/100 HOLD) after splitting the core matrix 0–8 (led by composite factor balance), while SANG wins 5–0 across the 6-pillar growth and valuation breakdown. VERS trades at $71.45 (N/M Forward P/E, N/A operating margin) versus SANG at $4.71 (N/M Forward P/E, -6.8% operating margin). Growth vs. Quality Trade-Off: VERS earns the overall head-to-head edge with a stronger Unified Composite Score (48.3/100 HOLD vs. SANG 48.5/100 HOLD) and 2.07β · 24% Vol risk profile, whereas SANG leads top-line expansion (-21.2% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.

SANG leads the Growth & Scale pillar: VERS posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with SANG at -21.2% YoY revenue growth and +0.0% YoY earnings growth on $200M TTM revenue (70.3% gross margin, -6.8% operating margin). On trailing 12-month operating scale, VERS generates N/A in USD-normalized revenue versus $200M for SANG. In operating R&D and SG&A reinvestment, VERS deploys N/A (0 90-day corporate R&D disclosures) versus 77.1% of Rev ($154M) (0 disclosures) for SANG.

SANG screens cheaper on headline valuation multiples. VERS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas SANG trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.8x EV/Revenue (2.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against VERS (N/A ROE) versus SANG (-37.8% ROE) capital efficiency.

In options market volatility and institutional positioning, VERS carries 57.2% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.07β · 24% Vol realized risk). By comparison, SANG carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.04β · 21% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.